| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/01/2009 | US20090005331 AChE antisense oligonucleotide as an anti-inflammatory agent |
| 01/01/2009 | US20090005329 Synthesizing 2'- beta -substituted phosphoramidites with pendent amine and carboxylate groups, oligomerization, coupling the pendent groups to form a nylon-DNA ladder copolymer; DNA nanotechnology; inhibition of antisense agent biosynthesis |
| 01/01/2009 | US20090005314 Compositions and Methods for Modulating Pgc-1Alpha to Treat Neurological Diseases and Disorders |
| 01/01/2009 | US20090005304 Human KCNQ5 potassium channel, methods and compositions thereof |
| 01/01/2009 | US20090005262 Methods, Compositions and Compound Assays for Inhibiting Amyloid-Beta Protein production |
| 01/01/2009 | US20090004733 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides, and uses thereof |
| 01/01/2009 | US20090004286 Compositions for achieving a therapeutic effect in an anatomical structure and methods of using the same |
| 01/01/2009 | US20090004260 Medicament comprising hgf gene |
| 01/01/2009 | US20090004240 Implants with a phosphazene-containing coating |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004207 Methods and Compositions for Inhibiting Pathological Angiogenesis in the Eye |
| 01/01/2009 | US20090004206 Polynucleotides and Polypeptide Sequences Involved in the Process of Bone Remodeling |
| 01/01/2009 | US20090004188 antibody that specifically binds to a human TNF Receptor in the BRAIN (TRAIN) polypeptide; useful in regulating cell differentiation, death, and survival |
| 01/01/2009 | US20090004169 Nucleic Acids For Inhibiting Hairless Protein Expression and Methods of Use Thereof |
| 01/01/2009 | US20090004163 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells |
| 01/01/2009 | US20090004158 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 01/01/2009 | US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE |
| 01/01/2009 | US20090004146 Humanised Baculovirus |
| 01/01/2009 | US20090004145 Compositions and methods involving gene therapy and proteasome modulation |
| 01/01/2009 | US20090004144 Recombinant Adeno-Associated Virus Vector for Treatment of Alzheimer Disease |
| 12/31/2008 | WO2009003125A1 Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
| 12/31/2008 | WO2009002918A2 Hepatitis c dsrna effector molecules, expression constructs, compositions, and methods of use |
| 12/31/2008 | WO2009002832A2 Inhibitors of ncca-atp channels for therapy |
| 12/31/2008 | WO2009002440A2 Compositions comprising human egfr-sirna and methods of use |
| 12/31/2008 | WO2009002380A2 Isolation of anti-desmoglein 1 antibodies by phage display of pemphigus foliaceus autoantibodies |
| 12/31/2008 | WO2009002376A1 Dna vaccine against north american spring viremia of carp virus |
| 12/31/2008 | WO2009001562A1 Compositions and methods of treating cancer |
| 12/31/2008 | WO2009001364A2 Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers |
| 12/31/2008 | WO2009001359A2 Compositions and methods for inhibiting expression of pro-apoptotic genes |
| 12/31/2008 | WO2009000555A1 Method of generating glucose-responsive cells |
| 12/31/2008 | WO2009000539A1 Modulation of production of retroviruses by apobec4 |
| 12/31/2008 | WO2008136852A9 Methods and compositions related to the structure and function of apobec3g |
| 12/31/2008 | WO2008064094A3 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof |
| 12/31/2008 | WO2007100808B1 Method and process for preparing cardiolipin |
| 12/31/2008 | WO2007100808A4 Method and process for preparing cardiolipin |
| 12/31/2008 | EP2009095A1 Method of generating glucose-responsive cells |
| 12/31/2008 | EP2008664A2 Modified proteins which bind extracellular matrix components |
| 12/31/2008 | EP2007906A2 Use of glis3 for preparing functional pancreatic beta-cells |
| 12/31/2008 | EP2007895A2 Compositions and methods for therapy of cystic fibrosis |
| 12/31/2008 | EP1750773B1 Drugs for the prevention or treatment of immunodeficiencies, autoimmune diseases or for the induction of immune tolerance |
| 12/31/2008 | EP1678193B1 Hepatocellular carcinoma specific promoter and uses thereof |
| 12/31/2008 | EP1549760B1 Sak: modulation of cellular proliferation for treatment of cancer |
| 12/31/2008 | EP1509600B1 Plant thymidine kinases and their use |
| 12/31/2008 | EP1425403B1 Lentiviral vectors for the treatment of pain |
| 12/31/2008 | EP1412503B1 A fusion protein |
| 12/31/2008 | EP1294872B1 Human trp-like calcium channel protein-2 (tlcc-2) |
| 12/31/2008 | EP1268761B1 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof |
| 12/31/2008 | EP1255850B1 Amplification of cyp24 and uses thereof |
| 12/31/2008 | EP1239042B1 Transposase and method of gene modification |
| 12/31/2008 | EP1212339B1 2'-o-acetamido modified monomers and oligomers |
| 12/31/2008 | EP1071471B1 Methods and vectors for making transgenic rodents which ubiquitously express a heterologous gene |
| 12/31/2008 | EP0989863B1 System for the in vivo delivery and expression of heterologous genes in the bone marrow |
| 12/31/2008 | CN101333530A Apoptosis-associated gene and medicaments for treating leucocythemia using the gene as target |
| 12/31/2008 | CN101333237A Oligonucleotide with breast carcinoma treating function |
| 12/31/2008 | CN101332304A Campylobacter jejuni chitose nano DNA vaccine and preparation method and use thereof |
| 12/31/2008 | CN101332185A SiRNA liposome preparation |
| 12/31/2008 | CN100447243C HBV specificity interference target point gene and its siRNA and application in anti HBV infecting thereof |
| 12/31/2008 | CN100446812C MVA expressing modified HIV envelope, GAG, and pol genes |
| 12/31/2008 | CA2698143A1 Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
| 12/31/2008 | CA2692171A1 Methods and uses thereof of prosaposin |
| 12/31/2008 | CA2692155A1 Compositions comprising human egfr-sirna and methods of use |
| 12/31/2008 | CA2692021A1 Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers |
| 12/31/2008 | CA2691510A1 Compositions and methods of treating cancer |
| 12/31/2008 | CA2691199A1 Inhibitors of ncca-atp channels for therapy |
| 12/30/2008 | US7470782 diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions |
| 12/30/2008 | US7470781 Formulation of stabilized cationic transfection agent(s)/nucleic acid particles |
| 12/30/2008 | US7470721 Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways |
| 12/30/2008 | US7470675 Methods for treating cancer using interferon-ω-expressing polynucleotides |
| 12/30/2008 | US7470673 Using vector comprising nucleotide sequences coding atonal-associated polypetides as therapeutic tool in treating hearing impairment and inflammatory bone disorders; antiarthritic agents |
| 12/30/2008 | US7470661 Delivery of superoxide dismutase to neuronal cells |
| 12/30/2008 | US7470538 Introducing enriched human endothelial generating cells and mesenchymal stem cells; enhancing vasculogenesis and collateralization around blocked and/or narrowed vessels |
| 12/30/2008 | US7470537 Adipose-derived stem cells and lattices |
| 12/30/2008 | US7470510 Methods for diagnosing cancer and determining a susceptibility for developing cancer |
| 12/30/2008 | US7470426 Treatment of neoplasms with viruses |
| 12/30/2008 | CA2245545C Vaccines against varicella zoster virus gene 63 product |
| 12/30/2008 | CA2132349C Chimeric receptor genes and cells transformed therewith |
| 12/25/2008 | US20080319178 Chimera humanized vascular endothelial growth factor |
| 12/25/2008 | US20080319174 Chimera humanized vascular endothelial growth factor |
| 12/25/2008 | US20080319173 Blood group antigen fusion polypeptides and methods of use thereof |
| 12/25/2008 | US20080319165 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least one neuropeptide |
| 12/25/2008 | US20080318896 Useful in the design of improved RNAi-mediating agents which allow for more exact control of the efficacy of RNA silencing; enhancing silencing of a target mRNA |
| 12/25/2008 | US20080318895 Intranasal delivery of nucleic acid molecules |
| 12/25/2008 | US20080318891 Antisense oligonucleotides against thymidylate synthase |
| 12/25/2008 | US20080318839 Ligand activated transcriptional regulator proteins |
| 12/25/2008 | US20080318835 Novel Integrin Ligand ITGL-TSP |
| 12/25/2008 | US20080318231 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer type |
| 12/25/2008 | US20080317783 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 12/25/2008 | US20080317782 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 12/25/2008 | US20080317772 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 12/25/2008 | US20080317759 Therapeutic uses of factors which inhibit or neutralize MIF activity |
| 12/25/2008 | US20080317754 Human Osteoclast Derived Cathepsin |
| 12/25/2008 | US20080317750 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 12/25/2008 | US20080317748 Using DCRS5 cytokine receptors modulators to treat psoriasis and atopic dermatitis |
| 12/25/2008 | US20080317746 Anti-Il2 Antibodies |
| 12/25/2008 | US20080317743 Human Artificial Chromosome Containing Human Antibody Lambda Light Chain Gene And Non-Human Animal Containing The Human Artificial Chromosome Capable Of Genetic Transmission |
| 12/25/2008 | US20080317723 Lymphatic endothelial cells materials and methods |
| 12/25/2008 | US20080317722 Methods and Compositions Involving Developmental Decision Promoter Regions |
| 12/24/2008 | WO2008157572A2 A method of treating abnormal angiogenesis via the bai family of proteins and their protein fragments |
| 12/24/2008 | WO2008157459A2 Methods and systems for identifying molecular pathway elements |
| 12/24/2008 | WO2008157419A2 Immunogenic peptides of influenza virus |